DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20203437

Treatment of psychological morbidity secondary to benign prostatic hyperplasia: a comparative study

Ayman A. Alqaralleh, Ashraf S. Al Majali, Alen M. Jaradat, Tareq G. Alnaser, Maysaa K. Abo Qamar, Belal A. Alkhawaldah, Qasem M. Alqaisi, Mohammad A. Abdeldayem, Mohammad A. Al Qudah

Abstract


Background: Authors tend to compare the medical treatment of benign prostatic hyperplasia with the surgical option regarding lower urinary tract symptoms (LUTS) and related psychological morbidity.

Methods: A retrospective study of (1614) patients who were managed by either transurethral resection of prostate (TURP) or medical treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia (BPH) over a period of 5 years between (Sep. 2013 and Sep. 2018) carried out in Prince Hussein Urology Center at Jordanian Royal Medical Services. Patients were classified into two groups, group1 (807 patients) who get a medical option and group 2 (807 patients who underwent TURPs. A comparison between both groups according to the effect of minimizing the psychological morbidities was done over a period of 1-year follow-up after reviewing the patient’s medical records.

Results: Ages of the patients for group1 and 2 were (47-68 years), (49-73 years), respectively. There were significant differences at the level of depression, anxiety and psychiatric morbidity pre-treatment between both groups p-value <0.05, and no significant differences after treatment in group 1 regarding these levels, p-value>0.05, but significant differences in the level of improvement after treatment between both groups and in group 2 were found, p-value <0.05.

Conclusions: The severity of LUTS and psychological morbidity have a positive relationship and were higher in the pretreatment surgical group, but the effect of TURP was superior to the medical group in the management of this morbidity and its causative (LUTS).


Keywords


Benign prostatic hyperplasia, Lower urinary tract symptoms, Medical treatment, Psychological morbidity, Transurethral resection of prostate

Full Text:

PDF

References


Mitropoulos D, Anastasiou I, Giannopoulou C, Nikolopoulos P, Alamanis C, Zervas A, et al. Symptomatic Benign Prostate Hyperplasia: Impact on Partners. 2019; Quality of Life. Eur Urol. 2002;41(3):240-5.

Chute CG, Panser LA, Girman CJ, Oesterling JE, Guess HA, Jacobsen SJ, et al. The prevalence of prostatism: a population-based survey of urinary symptoms. J Urol. 1993; 150(1):85-9.

Epstein RS, Deverka PA, Chute CG, Lieber MM, Oesterling JE, Panser L, et al. Urinary symptom and quality of lifequestions indicative of obstructive benign prostatic hyperplasia: Results of a pilot study. Urology. 1991 Jul 1;38(1):20-6.

Hunter DJ, McKee M, Black NA, Sanderson CF. Health status and quality of life of British men with lower urinary tract symptoms: results from the SF-36. Urology. 1995 Jun 1;45(6):962-71.

Sagnier PP, MacFarlane G, Teillac P, Botto H, Richard F, Boyle P. Impact of symptoms of prostatism on level of bother and quality of life of men in the French community. J Urol. 1995 Mar;153(3):669-73.

Donovan JL, Kay HE, Peters TJ, Abrams P, Coast J, Matos‐Ferreira A, et al. Using the ICSQoL to measure the impact of lower urinary tract symptoms on quality of life: Evidence from the ICS-‘BPH’study. British J Urol. 1997 Nov;80(5):712-21.

Girman CJ, Jacobsen SJ, Rhodes T, Guess HA, Roberts RO, Lieber MM. Association of health-related quality of life and benign prostatic enlargement. Eur Urol. 1999;35(4):277-84.

Girman CJ, Epstein RS, Jacobsen SJ, Guess HA, Panser LA, Oesterling JE, Lieber MM. Natural history of prostatism: impact of urinary symptoms on quality of life in 2115 randomly selected community men. Urology. 1994 Dec 1;44(6):825-31.

Creamer M, Foran J, Bell R. The Beck Anxiety Inventory in a non-clinical sample. Behaviour research and Therapy. 1995 May 1;33(4):477-85.

Spielberger CD. State‐Trait anxiety inventory. The Corsini encyclopedia of psychology. 2010 Jan 30:1.

del Pilar Sánchez-López M, Dresch V. The 12-Item General Health Questionnaire (GHQ-12): reliability, external validity and factor structure in the Spanish population. Psicothema. 2008;20(4):839-43.

Dunphy C, Laor L, Te A, Kaplan S, Chughtai B. Relationship Between Depression and Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Rev Urol. 2015;17(2):51-7.

Pietrzyk B, Olszanecka-Glinianowicz M, Owczarek A. Depressive symptoms in patients diagnosed with benign prostatic hyperplasia. Int Urol Nephrol. 2015;47(3):431-40.

Koh JS, Ko HJ, Wang SM, Cho KJ, Kim JC, Lee SJ, Pae CU. The relationship between depression, anxiety, somatization, personality and symptoms of lower urinary tract symptoms suggestive of benign prostatic hyperplasia. Psych Investigation. 2015 Apr;12(2):268.

Zhang W, Zhang X, Li H, Wu F, Wang H, Zhao M, et al. Prevalence of lower urinary tract symptoms suggestive of benign prostatic hyperplasia (LUTS/BPH) in China: results from the China Health and Retirement Longitudinal Study. BMJ open. 2019 Jun 1;9(6):e022792.

Vasanwala FF, Wong MYC, Ho HSS, Foo KT. Benign prostatic hyperplasia and male lower urinary symptoms: A guide for family physicians. Asian J Urol. 2017;4(3):181-4.

Phillips BL, Brown GP, Greenlees M, Webb JK, Shine R. Rapid expansion of the cane toad (Bufo marinus) invasion front in tropical Australia. Austral Ecol. 2007 Apr;32(2):169-76.

Quek KF, Low WY, Razack AH, Loh CS. The psychological effects of treatments for lower urinary tract symptoms. BJU Int. 2000;86(6):630‐3.